Abstract PS14-01: Radium-223 in women with HR-positive bone-metastatic breast cancer receiving endocrine therapy: International phase 2, randomized, double-blind, placebo-controlled trialRobert E. Coleman, Hope S. Rugo, Sung‐Bae Kim et al.|Cancer Research|2021Cited by 3